Nivolumab is a monoclonal antibody-based immunotherapy used in the treatment of several cancers, including lung and head-and-neck cancers
Vous n'êtes pas connecté
Maroc - COURTHOUSENEWS.COM - 21/Jan 22:35
ST. PAUL, Minn. — Target was partially denied its motion to dismiss a Minnesota federal class action filed by shoppers who purchased an acne treatment later linked to leukemia and other blood cancers. The court dismissed the claims for injunctive relief, but found the shoppers can pursue their “misbranding” claim if Target’s labels failed to disclose the presence of a dangerous chemical. The court also finds shoppers can pursue the “adulteration” claim because Target’s product plausibly contains benzene.
Nivolumab is a monoclonal antibody-based immunotherapy used in the treatment of several cancers, including lung and head-and-neck cancers
Nivolumab is a monoclonal antibody-based immunotherapy used in the treatment of several cancers, including lung and head-and-neck cancers
Acute myeloid leukemia, often called AML, is one of the most aggressive and difficult blood cancers to treat. Every year thousands of people are...
Acute myeloid leukemia, often called AML, is one of the most aggressive and difficult blood cancers to treat. Every year thousands of people are...
The BBC will ask a judge to dismiss...
The BBC will ask a judge to dismiss...
Earlier on Tuesday, Ben-Gvir asked the court to dismiss the petitions outright, arguing that the High Court has no authority to rule on the dismissal...
Earlier on Tuesday, Ben-Gvir asked the court to dismiss the petitions outright, arguing that the High Court has no authority to rule on the dismissal...
The BBC plans to ask a court to throw out U.S. President Donald Trump's $10 billion lawsuit against the British broadcaster, court papers show. ......
The BBC plans to ask a court to throw out U.S. President Donald Trump's $10 billion lawsuit against the British broadcaster, court papers show. ......